BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31811943)

  • 21. GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins.
    Xia M; Liu CJ; Zhang Q; Guo AY
    Cells; 2019 Jul; 8(7):. PubMed ID: 31277321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Transcriptomic Analysis of Necrosis-related Gene in Diffuse Gliomas.
    Wang J; Ma J
    J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):240-249. PubMed ID: 30934097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer.
    Deng X; Das S; Kaur H; Wilson E; Camphausen K; Shankavaram U
    BMC Med Genomics; 2023 Jul; 16(1):168. PubMed ID: 37454191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Big data visualization identifies the multidimensional molecular landscape of human gliomas.
    Bolouri H; Zhao LP; Holland EC
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5394-9. PubMed ID: 27118839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
    Jia D; Li S; Li D; Xue H; Yang D; Liu Y
    Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status.
    Li G; Wang Z; Zhang C; Liu X; Yang F; Sun L; Liang J; Hu H; Liu Y; You G; Bao Z; Zhang W; Wang Z; Jiang T
    Dis Markers; 2018; 2018():5975216. PubMed ID: 29887919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging Atlas: a multi-omics database for aging biology.
    Aging Atlas Consortium
    Nucleic Acids Res; 2021 Jan; 49(D1):D825-D830. PubMed ID: 33119753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using genomics to guide treatment for glioblastoma.
    Young JS; Prados MD; Butowski N
    Pharmacogenomics; 2018 Oct; 19(15):1217-1229. PubMed ID: 30203716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PiiL: visualization of DNA methylation and gene expression data in gene pathways.
    Moghadam BT; Zamani N; Komorowski J; Grabherr M
    BMC Genomics; 2017 Aug; 18(1):571. PubMed ID: 28768481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMIVD: DNA methylation interactive visualization database.
    Ding W; Chen J; Feng G; Chen G; Wu J; Guo Y; Ni X; Shi T
    Nucleic Acids Res; 2020 Jan; 48(D1):D856-D862. PubMed ID: 31598709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OMCD: OncomiR Cancer Database.
    Sarver AL; Sarver AE; Yuan C; Subramanian S
    BMC Cancer; 2018 Dec; 18(1):1223. PubMed ID: 30522456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    Lu J; Cowperthwaite MC; Burnett MG; Shpak M
    PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of microRNA expression profile in malignant glioma tissues.
    Piwecka M; Rolle K; Belter A; Barciszewska AM; Żywicki M; Michalak M; Nowak S; Naskręt-Barciszewska MZ; Barciszewski J
    Mol Oncol; 2015 Aug; 9(7):1324-40. PubMed ID: 25864039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
    Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma.
    Zeng A; Yin J; Li Y; Li R; Wang Z; Zhou X; Jin X; Shen F; Yan W; You Y
    Cell Death Dis; 2018 Mar; 9(3):394. PubMed ID: 29531296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating Genomic Data with Transcriptomic Data for Improved Survival Prediction for Adult Diffuse Glioma.
    Yang Q; Xiong Y; Jiang N; Zeng F; Huang C; Li X
    J Cancer; 2020; 11(13):3794-3802. PubMed ID: 32328184
    [No Abstract]   [Full Text] [Related]  

  • 40. Identifying the personalized driver gene sets maximally contributing to abnormality of transcriptome phenotype in glioblastoma multiforme individuals.
    Xu J; Pang B; Lan Y; Dou R; Wang S; Kang S; Zhang W; Liu Y; Zhang Y; Ping Y
    Mol Oncol; 2023 Nov; 17(11):2472-2490. PubMed ID: 37491836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.